XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Series C Preferred Stock
Preferred Stock
Series C Preferred Stock
Preferred Stock
Series B Preferred Stock
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Series C Preferred Stock
Accumulated Deficit
Accumulated Other Comprehensive Income
Revision of Prior Period, Accounting Standards Update, Adjustment
Revision of Prior Period, Accounting Standards Update, Adjustment
Accumulated Deficit
Balance (in shares) at Dec. 31, 2018       8,000,000 449,787,000            
Balance at Dec. 31, 2018 $ 3,416,101     $ 80 $ 4,498 $ 3,623,275   $ (632,040) $ 420,288    
Increase (Decrease) in Stockholders' Equity                      
Net income/(loss) 88,857             88,857      
Issuance of stock, net of expenses (in shares)         1,066,000            
Issuance of stock, net of expenses 551       $ 7 544          
Repurchase of shares of common stock (in shares) [1]         (370,000)            
Repurchase of shares of common stock [1] (2,610)         (2,610)          
Equity based compensation expense 992         992          
Accrued dividends attributable to stock-based awards 435         435          
Dividends declared on common stock ($0.20 per share) (90,097)             (90,097)      
Dividends declared on preferred stock ($0.46875 per share) (3,750)             (3,750)      
Dividends attributable to dividend equivalents (256)             (256)      
Change in unrealized gains on MBS, net 5,094               5,094    
Derivative hedging instrument fair value changes and amortization, net (10,786)               (10,786)    
Balance (in shares) at Mar. 31, 2019       8,000,000 450,483,000            
Balance at Mar. 31, 2019 3,404,531     $ 80 $ 4,505 3,622,636   (637,286) 414,596    
Balance (in shares) at Dec. 31, 2018       8,000,000 449,787,000            
Balance at Dec. 31, 2018 3,416,101     $ 80 $ 4,498 3,623,275   (632,040) 420,288    
Increase (Decrease) in Stockholders' Equity                      
Net income/(loss) 181,897                    
Dividends declared on preferred stock ($0.46875 per share) (7,500)                    
Balance (in shares) at Jun. 30, 2019       8,000,000 450,622,000            
Balance at Jun. 30, 2019 3,403,373     $ 80 $ 4,506 3,625,399   (638,396) 411,784    
Increase (Decrease) in Stockholders' Equity                      
Adjustments related to tax withholding for share-based compensation         $ 2,600            
Shares paid for tax withholding for share based compensation (in shares)         370,244            
Balance (in shares) at Mar. 31, 2019       8,000,000 450,483,000            
Balance at Mar. 31, 2019 3,404,531     $ 80 $ 4,505 3,622,636   (637,286) 414,596    
Increase (Decrease) in Stockholders' Equity                      
Net income/(loss) 93,040             93,040      
Issuance of stock, net of expenses (in shares)         139,000            
Issuance of stock, net of expenses 586       $ 1 585          
Equity based compensation expense 2,438         2,438          
Accrued dividends attributable to stock-based awards (260)         (260)          
Dividends declared on common stock ($0.20 per share) (90,124)             (90,124)      
Dividends declared on preferred stock ($0.46875 per share) (3,750)             (3,750)      
Dividends attributable to dividend equivalents (276)             (276)      
Change in unrealized gains on MBS, net 17,637               17,637    
Derivative hedging instrument fair value changes and amortization, net (20,449)               (20,449)    
Balance (in shares) at Jun. 30, 2019       8,000,000 450,622,000            
Balance at Jun. 30, 2019 3,403,373     $ 80 $ 4,506 3,625,399   (638,396) 411,784    
Balance (in shares) at Dec. 31, 2019     0 8,000,000 452,369,000            
Balance at Dec. 31, 2019 3,383,952   $ 0 $ 80 $ 4,524 3,640,341   (631,040) 370,047 $ (8,326) $ (8,326)
Increase (Decrease) in Stockholders' Equity                      
Net income/(loss) (908,995)             (908,995)      
Issuance of stock, net of expenses (in shares)     11,000,000   1,106,000            
Issuance of stock, net of expenses 687 $ 266,029 $ 110   $ 7 680 $ 265,919        
Repurchase of shares of common stock (in shares) [2]         (337,000)            
Repurchase of shares of common stock [2] (2,652)         (2,652)          
Equity based compensation expense 1,266         1,266          
Accrued dividends attributable to stock-based awards 1,059         1,059          
Change in unrealized gains on MBS, net (243,812)               (243,812)    
Derivative hedging instrument fair value changes and amortization, net (48,533)               (48,533)    
Balance (in shares) at Mar. 31, 2020     11,000,000 8,000,000 453,138,000            
Balance at Mar. 31, 2020 2,440,675   $ 110 $ 80 $ 4,531 3,906,613   (1,548,361) 77,702    
Balance (in shares) at Dec. 31, 2019     0 8,000,000 452,369,000            
Balance at Dec. 31, 2019 3,383,952   $ 0 $ 80 $ 4,524 3,640,341   (631,040) 370,047 $ (8,326) $ (8,326)
Increase (Decrease) in Stockholders' Equity                      
Net income/(loss) (812,417)                    
Dividends declared on preferred stock ($0.46875 per share) (13,359)                    
Balance (in shares) at Jun. 30, 2020     11,000,000 8,000,000 453,244,000            
Balance at Jun. 30, 2020 2,521,051   $ 110 $ 80 $ 4,532 3,922,399   (1,451,783) 45,713    
Increase (Decrease) in Stockholders' Equity                      
Adjustments related to tax withholding for share-based compensation         $ 2,700            
Shares paid for tax withholding for share based compensation (in shares)         337,026            
Balance (in shares) at Mar. 31, 2020     11,000,000 8,000,000 453,138,000            
Balance at Mar. 31, 2020 2,440,675   $ 110 $ 80 $ 4,531 3,906,613   (1,548,361) 77,702    
Increase (Decrease) in Stockholders' Equity                      
Net income/(loss) 96,578             96,578      
Issuance of stock, net of expenses (in shares)         106,000            
Issuance of stock, net of expenses 37       $ 1 36          
Equity based compensation expense 1,709         1,709          
Dividends declared on preferred stock ($0.46875 per share) (8,144)                    
Change in unrealized gains on MBS, net (96,021)               (96,021)    
Derivative hedging instrument fair value changes and amortization, net 64,032               64,032    
Warrants Issued 14,041                    
Balance (in shares) at Jun. 30, 2020     11,000,000 8,000,000 453,244,000            
Balance at Jun. 30, 2020 $ 2,521,051   $ 110 $ 80 $ 4,532 $ 3,922,399   $ (1,451,783) $ 45,713    
[1] For the six months ended June 30, 2019, includes approximately $2.6 million (370,244 shares) surrendered for tax purposes related to equity-based compensation awards.

[2] For the six months ended June 30, 2020 includes approximately $2.7 million (337,026 shares) surrendered for tax purposes related to equity-based compensation awards.